S. Matetzky et al., Smoking increases tissue factor expression in atherosclerotic plaques - Implications for plaque thrombogenicity, CIRCULATION, 102(6), 2000, pp. 602-604
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Smoking increases the risk of atherothrombotic events. To determ
ine whether smoking influences plaque thrombogenicity, we examined the effe
ct of cigarette smoking and aspirin use on tissue factor (TF) expression in
atherosclerotic plaques.
Methods and Results-A total of 23 apoE-/- mice were exposed to cigarette sm
oke with (n=9) or without (n= 14) aspirin treatment. Eleven mice who were e
xposed to filtered room air served as controls. Aortic root plaques of mice
exposed to smoke had higher immunoreactivity for TF (14 +/- 4% versus 6.4
+/- 3%; P=0.0005), vascular cell adhesion molecule-1 (15+/-4% versus 5+/-2%
; P=0.002), and macrophages (16+/-5% versus 6+/-2%; P=0.002) compared with
nonsmoking controls. Aspirin treatment attenuated smoking-induced changes i
n plaque composition. In human plaques obtained by carotid endarterectomy,
TF immunoreactivity ((8+/-5% versus 2+/-2%; P=0.0002) and activity (P=0.03)
were higher in the plaques from smokers (n=28) than those from nonsmokers
(n=28). Aspirin use was associated with reduced TF expression in smokers (9
+/-8% versus 3+/-4%; P=0.0017).
Conclusions-Our results suggest increased plaque TF expression and thrombog
enicity as a novel mechanism for the increased risk of atherothrombotic eve
nts in smokers. Treatment with aspirin may reduce TF expression.